Proteomics/Modifier Based on Mass Spectrometry Reveals the Pathogenesis of Eclampsia During Pregnancy and the Screening of Disease Markers
NCT04833881
·
clinicaltrials.gov ↗
UNKNOWN
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Mechanism
Marker Screening
Interventions
OTHER:
Sponsor
Heilongjiang University of Chinese Medicine